COVID-19 Illness and Heart Failure
- 9 April 2020
- journal article
- editorial
- Published by Elsevier BV in JACC: Heart Failure
- Vol. 8 (6), 512-514
- https://doi.org/10.1016/j.jchf.2020.03.004
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?The Lancet Respiratory Medicine, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Chimeric Antigen Receptor T-Cell Therapy for Cancer and HeartJournal of the American College of Cardiology, 2019
- Seasonal Influenza Infections and Cardiovascular Disease MortalityJAMA Cardiology, 2016
- Heart failure in diabetes: effects of anti-hyperglycaemic drug therapyThe Lancet, 2015
- Heart Failure Induced by Non-Cardiac DrugsDrug Safety, 2006
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor TherapyAnnals of Internal Medicine, 1992